Dyslipidemia is an emerging mechanism in microvascular complications in T2D. Elucidating
the molecular pathomechanisms may pinpoint potential lipid-centric treatments …

The current paradigm of type 2 diabetes (T2D) is gluco-centric, being exclusively
categorized by glycemic characteristics. The gluco-centric paradigm views hyperglycemia as …

Introduction Dyslipidemia is a major risk factor for cardiovascular diseases (CVD). The
prevalence of dyslipidemia is not known among Ethiopian adults. The prevalence is …

Objective Dyslipidemia is one of the major public health problems in China. It is
characterized by multisystem dysregulation and inflammation, and oxidant/antioxidant …

Diabetic nephropathy (DN) is a primary cause of end‑stage renal disease. Despite the
beneficial effects of astragaloside IV (AS)‑IV on renal disease, the underlying mechanism of …

Background Dyslipidemia is one of the major modifiable risk factors for cardiovascular
diseases (CVD) in a type-2 diabetic (T2DM) patient. Dyslipidemia in T2DM patients is …

Dyslipidemia is considered a significant modifiable risk factor for type-2 diabetes mellitus
(T2DM) and has become one of the emerging health problems throughout the world. In …

Background Type 2 diabetes mellitus (T2DM) is a worldwide health problem. Prolonged
elevated glucose level might cause serious cardiovascular complications. MicroRNA-499 …

Methods: This was a descriptive cross-sectional study in 355 type 2 diabetic patients at
tertiary care hospital from 15th May, 2020 to 15th November, 2020 after taking ethical …

Purpose Dyslipidemia is a major risk factor for cardiovascular disease (CVD) in diabetic
patients and early detection and treatment can reduce its morbidity and mortality. There is …